Bristol Myers Squibb (BMY) Construction in Progress (2015 - 2026)
Bristol Myers Squibb's Construction in Progress was $1.3 billion in Q2 2026, down 26.4% from $1.76 billion a year earlier and down 15.9% from the prior quarter.
Powered by 
Analysis
Bristol Myers Squibb (BMY) Construction in Progress (2015 - 2026) Analysis & Trends
At the end of FY2025, Construction in Progress at Bristol Myers Squibb came in at $1.62 billion, up 6.2% from FY2024.
- Construction in Progress has now increased for five consecutive years, with a five-year compound annual growth rate of 27.2% (FY2020 to FY2025).
- In earlier years, Construction in Progress was $1.53 billion in FY2024 (+41.9%), $1.08 billion in FY2023 (+2.1%), $1.05 billion in FY2022 (+37.8%) and $764 million in FY2021 (+56.9%).
- The Q2 2026 figure marks the lowest quarterly Construction in Progress since Q2 2024.
- Compared with a year earlier, Construction in Progress was higher in six of the last eight quarters, with growth averaging 15.1%.
- The best year-over-year quarter for Construction in Progress over five years was Q3 2021 (growth of 69.9%); the worst was Q2 2026 (a decline of 26.4%).
- Per Business Quant data, BMY's Construction in Progress in the three quarters before Q2 2026 was $1.54 billion (Q1 2026), $1.62 billion (Q4 2025) and $1.46 billion (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Construction in Progress (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,160.36 Bn | 1,128.95 Bn | 19.71 Bn | - |
| 2 | Johnson & Johnson | 626.36 Bn | 544.88 Bn | 17.26 Bn | - |
| 3 | AbbVie | 510.70 Bn | 483.81 Bn | 12.70 Bn | - |
| 4 | Merck | 366.42 Bn | 320.80 Bn | 12.21 Bn | - |
| 5 | Novartis Ag | 296.57 Bn | 260.56 Bn | 11.24 Bn | - |
| 6 | Astrazeneca | 261.07 Bn | 234.75 Bn | 12.86 Bn | - |
| 7 | Amgen | 235.19 Bn | 190.59 Bn | 7.24 Bn | - |
| 8 | Gilead Sciences | 193.08 Bn | 167.27 Bn | 6.22 Bn | - |
| 9 | Pfizer | 171.00 Bn | 117.64 Bn | 10.94 Bn | - |
| 10 | Bristol Myers Squibb | 124.99 Bn | 76.26 Bn | 9.25 Bn | 1.30 Bn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 1.30 Bn |
| Mar 31, 2026 | 1.54 Bn |
| Dec 31, 2025 | 1.62 Bn |
| Sep 30, 2025 | 1.46 Bn |
| Jun 30, 2025 | 1.76 Bn |
| Mar 31, 2025 | 1.66 Bn |
| Dec 31, 2024 | 1.53 Bn |
| Sep 30, 2024 | 1.37 Bn |
| Jun 30, 2024 | 1.26 Bn |
| Mar 31, 2024 | 1.21 Bn |
| Dec 31, 2023 | 1.08 Bn |
| Sep 30, 2023 | 1.11 Bn |
| Jun 30, 2023 | 1.20 Bn |
| Mar 31, 2023 | 1.07 Bn |
| Dec 31, 2022 | 1.05 Bn |
| Sep 30, 2022 | 973.00 Mn |
| Jun 30, 2022 | 850.00 Mn |
| Mar 31, 2022 | 800.00 Mn |
| Dec 31, 2021 | 764.00 Mn |
| Sep 30, 2021 | 695.00 Mn |
API Access
Bristol Myers Squibb Construction in Progress API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=construction-in-progress&ticker=BMY&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "construction-in-progress", "ticker": "BMY", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=construction-in-progress&ticker=BMY&period=max&api_key=YOUR_API_KEY");
const data = await res.json();